PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $475,000 | +0.6% | 12,582 | -12.8% | 0.00% | 0.0% |
Q1 2018 | $472,000 | -55.1% | 14,437 | -33.1% | 0.00% | -57.1% |
Q4 2017 | $1,051,000 | +266.2% | 21,582 | +306.4% | 0.01% | +250.0% |
Q3 2017 | $287,000 | +13.4% | 5,310 | +18.0% | 0.00% | 0.0% |
Q2 2017 | $253,000 | +36.0% | 4,501 | -42.9% | 0.00% | +100.0% |
Q2 2016 | $186,000 | +34.8% | 7,889 | +16.9% | 0.00% | 0.0% |
Q1 2016 | $138,000 | -39.5% | 6,749 | +52.3% | 0.00% | -50.0% |
Q4 2015 | $228,000 | -0.9% | 4,430 | -18.0% | 0.00% | 0.0% |
Q3 2015 | $230,000 | +202.6% | 5,405 | +222.9% | 0.00% | +100.0% |
Q2 2015 | $76,000 | +68.9% | 1,674 | +42.0% | 0.00% | – |
Q1 2015 | $45,000 | +40.6% | 1,179 | +3.4% | 0.00% | – |
Q4 2014 | $32,000 | +14.3% | 1,140 | +2.2% | 0.00% | – |
Q3 2014 | $28,000 | -15.2% | 1,116 | -2.7% | 0.00% | – |
Q2 2014 | $33,000 | +37.5% | 1,147 | +22.9% | 0.00% | – |
Q1 2014 | $24,000 | +41.2% | 933 | +40.1% | 0.00% | – |
Q4 2013 | $17,000 | – | 666 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,220,672 | $55,602,000 | 9.30% |
Fernwood Investment Management, LLC | 201,211 | $9,165,000 | 7.20% |
Cormorant Asset Management, LP | 500,000 | $22,775,000 | 3.03% |
Ghost Tree Capital, LLC | 170,000 | $7,744,000 | 2.51% |
HARVEY CAPITAL MANAGEMENT INC | 155,030 | $7,108,000 | 2.40% |
SECTORAL ASSET MANAGEMENT INC | 1,169,130 | $53,254,000 | 2.22% |
Atika Capital Management LLC | 98,000 | $4,464,000 | 2.01% |
Temasek Holdings (Private) Ltd | 5,833,568 | $265,719,000 | 1.66% |
CABOT WEALTH MANAGEMENT INC | 124,309 | $5,662,000 | 1.38% |
EMERALD MUTUAL FUND ADVISERS TRUST | 314,689 | $14,334,000 | 1.11% |